Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Tumor specific fluorescent contrast agents
Samuel Achilefu
, Richard B. Dorshow
, Joseph E. Bugaj
, Raghavan Rajagopalan
Division of Radiological Sciences
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Bursky Center for Human Immunology and Immunotherapy
Biophotonics Research Center
Research output
:
Contribution to journal
›
Conference article
›
peer-review
9
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tumor specific fluorescent contrast agents'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Benign or Malignant
50%
Benign Tumor
50%
Biocompatibility
50%
Biomedical Applications
50%
Biomolecules
50%
Disease States
50%
Fluorescent Agents
100%
Immunogenic
50%
Inflammation
50%
Large Biomolecules
50%
Liver
50%
Malignant Tumor
50%
Mechanism of Action
50%
Metabolic Activity
50%
Molar Absorptivity
50%
Optical Image
50%
Peptide Conjugates
50%
Proliferating Cells
50%
Rat Tumor
50%
Solid Tumors
50%
Tumor
50%
Tumor Targeting
50%
Tumor-specific
100%
Vasculature
100%
Immunology and Microbiology
Cell Proliferation
50%
Conjugate
100%
Contrast Medium
100%
Peptides
50%
Vascularization
100%
Biochemistry, Genetics and Molecular Biology
Cell Proliferation
50%
Conjugate
100%
Contrast Medium
100%
Facilitated Diffusion
50%
Vascularization
100%
Pharmacology, Toxicology and Pharmaceutical Science
Benign Neoplasm
25%
Biocompatibility
25%
Biological Marker
25%
Contrast Medium
100%
Inflammation
25%
Malignant Neoplasm
25%
Neoplasm
100%
Receptor
25%
Solid Malignant Neoplasm
25%
Material Science
Biocompatibility
25%
Cell Proliferation
25%
Contrast Medium
100%
Tumor
100%